Records containing: Type 2 Diabetes
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-12-18Enhancing Proactive and Preventative Health Behaviors Among Hyperglycemic Patients Presenting to the Emergency Department
-
CLINICAL_TRIALS study record update · 2024-12-17Safety and Efficacy of OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Refractory Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2024-12-16The Effect of Lixisenatide on Postprandial Lipid and Glucose Metabolism in Patients with Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2024-12-16A Multicenter, Pivotal, Randomized Controlled Trial Comparing the Safety and Efficacy of an Automated Insulin Delivery System With the Standard of Care in Adults With Type 2 Diabetes (EMBRACE-T2D)
-
CLINICAL_TRIALS study record update · 2024-12-13An Open-Label, Single-Arm, Phase 4 Study to Assess Glycemic Control When Adults With Type 2 Diabetes Switch From a GLP-1 RA to Tirzepatide (SURPASS-SWITCH-2)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-12-13A Phase 1 Randomized, Single-blind, Placebo-controlled, First-in-Human and Sequential Group Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186 Following Single Ascending Doses Via Oral Administration
-
CLINICAL_TRIALS study record update · 2024-12-13A Randomized, Open-label, Single Dose, Two-way Replicate Crossover Phase 1 Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2024-12-12A Non-inferiority Randomized Trial Testing an Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality
-
CLINICAL_TRIALS study record update · 2024-12-11Non-REm Sleep inTervention to improvE Diabetes RESTED
-
CLINICAL_TRIALS study record update · 2024-12-10A Randomized, Double-blind, Multi-center, Therapeutic Confirmatory, Phase 3 Trial to Evaluate the Efficacy and Safety of D150, D745 and D759 Combination Therapy in Pateints with Type 2 Diabetes Inadequately Controlled with D150 Plus D759
-
CLINICAL_TRIALS study record update · 2024-12-09Sympathomimetics and Sympatholytics in Type 2 Diabetes: Teaching Old Drugs New Tricks
-
CLINICAL_TRIALS study record update · 2024-12-09Insulin Degludec Versus Glargine U300 for the Management of Hospitalized Patients With Type 2 Diabetes: Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-12-06Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity
-
CLINICAL_TRIALS study record update · 2024-12-06Chronotherapy with Low-dose Aspirin for Primary Prevention of Cardiovascular Events in Subjects with Impaired Fasting Glucose or Diabetes (CARING Study).
-
CLINICAL_TRIALS study record update · 2024-12-04Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
-
CLINICAL_TRIALS study record update · 2024-12-04Application of Time Restriction Feeding in Patients With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2024-12-03Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction
-
CLINICAL_TRIALS study record update · 2024-12-02A Person-centred and Culturally Sensitive Course of Treatment Targeting Individuals With Type 2 Diabetes and Non-Western Backgrounds (The ACCT2 Study)
-
CLINICAL_TRIALS study record update · 2024-11-29A Clinical Study Comparing Effects of Empagliflozin Versus Vildagliptin on Inflammatory Biomarkers, and Atrial Function in Coronary Artery Disease Patients With Type 2 Diabetes: EMBA-VILDA-Response Trial.
-
CLINICAL_TRIALS study record update · 2024-11-27A Retrospective Chart Review Combined With a Prospective Cross-sectional Survey and Interviews on Patients With Type 2 Diabetes Mellitus to Assess Effectiveness of Adding SodiumGlucose Co-transporter 2 Inhibitor to Gliclazide Modified Release
-
CLINICAL_TRIALS study record update · 2024-11-26Observational Cohort Study Evaluating the Effectiveness of an Education Program (NGAYDAUTIEN) in Combination With Gliclazide MR in the Management of Uncontrolled Type 2 Diabetic Patients.
-
CLINICAL_TRIALS study record update · 2024-11-25A Multicenter, Randomized, Open-label, Controlled Study on Evaluating the Efficacy and Safety of Switching From Daily DPP-4 Inhibitors to HSK7653 Tablets in Patients With Type 2 Diabetes Mellitus in China
-
CLINICAL_TRIALS study record update · 2024-11-22A Randomized Controlled Trial for Liver Fibrosis Assessment in Diabetic Patients
-
CLINICAL_TRIALS study record update · 2024-11-21Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics with Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM)
-
CLINICAL_TRIALS study record update · 2024-11-20Dietary Approaches to Stop Hypertension for Diabetes Trial